NEOGEN CHEMICALS RAISES ₹600 CRORE VIA QIP

N Chemicals Limited has completed its first-ever Qualified Institutional Placement, raising nearly ₹600 crore. The QIP was oversubscribed by more than 6.5 times, indicating strong institutional demand for the issue. The company allotted around 26.6 lakh equity shares at ₹2,255 per share. Interestingly, the issue price was above the QIP floor price of ₹2,189.73. The fundraise saw participation from domestic and global institutional investors, including mutual funds, insurance companies and foreign portfolio investors. Why does this matter? Neogen plans to use the proceeds partly for repayment or prepayment of borrowings and long-term working capital requirements. Reducing debt could lower finance costs and improve the company’s debt-to-equity position, while additional working capital provides room to support future expansion. My view: The 6.5x subscription is an important signal of institutional interest, but the bigger fundamental trigger will be how efficiently the fresh capital translates into balance-sheet improvement and earnings growth. The stock has already seen a strong run in 2026, so valuation and execution become increasingly important from here. What I am watching next: Track debt reduction over the coming quarters, working-capital trends and management commentary on deployment of the QIP proceeds. For the stock, the recent 52-week high near ₹2,498 becomes an important reference zone. Sustained strength above this area could indicate continuation of momentum, while failure to hold recent gains may lead to consolidation. View: Positive development fundamentally, but fresh entries should consider valuation and price confirmation. Disclosure: I have no holding or financial interest in Neogen Chemicals Limited.